If investors are looking for a solid dividend stock with upside potential, Johnson & Johnson (NYSE: JNJ) could be one that ticks all the boxes. The stock currently provides a dividend yield of 2.57% for the Healthcare company. Research analysts covering the stock are projecting that it will reach $149.48 within the next year.Let’s take a look at how the stock has been performing recently. Over the past twelve months, Johnson & Johnson (NYSE: JNJ)’s stock was -6.51%. Over the last week of the month, it was 1.97%, -9.79% over the last quarter, and -4.41% for the past six months. Over the past 50 days, Johnson & Johnson stock’s -6.59% off of the high and 7.57% removed from the low. Their 52-Week High and Low are noted here. -11.41% (High), 8.64%, (Low). Investors sentiment increased to 0.87 in 2017 Q4. Its up 0.04, from 0.83 in 2017Q3. It is positive, as 35 investors sold Johnson & Johnson shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. analyze more $JNJ